Postpartum depression often goes undiagnosed because of a lack of screening and stigma—learn how early detection, open conversations, and new treatment options can improve outcomes for mothers.
In this video, Joy Baker, MD, FACOG, ob-gyn at Wellstar West Georgia Medical Center, discusses the often-overlooked issue of mental health conditions during and after pregnancy, particularly postpartum depression.
Baker highlighted that while physical complications such as high blood pressure and diabetes are routinely monitored during pregnancy, mental health is frequently neglected. One of the major barriers to addressing postpartum depression is the lack of consistent screening. Many clinicians are not adequately trained to identify or manage mental health conditions during the perinatal period, often receiving minimal education on the topic during medical training.
Baker noted that even when screenings are conducted and patients are identified as being at risk, there is often uncertainty about the next steps because of a shortage of mental health providers. This gap in the care continuum discourages some clinicians from screening at all.
On the patient side, stigma and fear play significant roles. Many pregnant and postpartum individuals worry that admitting to depression or anxiety will label them as unfit parents, potentially leading to social or legal consequences such as losing custody of their child. The societal expectation that motherhood should be a blissful and seamless experience adds to the pressure and shame many mothers feel when they struggle emotionally.
Baker stressed the importance of approaching these issues with curiosity and empathy. When a patient expresses feelings of being overwhelmed or emotionally distressed, it should prompt further discussion and screening. Postpartum depression doesn't always present in expected ways, with symptoms including irritability, anxiety, or even rage. Therefore, clinicians must be trained to recognize these varied expressions and to translate a patient’s narrative into clinical terms. Asking straightforward, relatable questions—such as about changes in sleep, appetite, or mood—can make it easier for patients to open up.
She also emphasized the importance of clinician education and routine use of validated screening tools such as the Edinburgh Postnatal Depression Scale or PHQ-9. However, she cautioned that screening tools are just a starting point and that meaningful conversations with patients are essential for accurate diagnosis and treatment planning.
Encouragingly, Baker noted that there are now FDA-approved treatments, including oral medications and therapy options, which are effective in treating postpartum depression. She concluded by urging clinicians to screen early and often and to become informed about available treatment options so they can better support their patients' mental and emotional well-being.
Disclosures: No relevant disclosures.
Reference:
Baker J. Decoding “overwhelmed” & why some patients with PPD are overlooked. Presented at: 2025 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting. May 16-18, 2025. Minneapolis, Minnesota.
Low recurrence found after uterine rupture in pregnancy
May 17th 2025A new study presented at the 2025 ACOG Annual Clinical & Scientific Meeting found that while recurrent uterine rupture is rare, patients with a history of rupture face a significantly increased subsequent risk of preterm delivery.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Self-screening tool for medication abortion found accurate and acceptable
May 17th 2025A new study presented at the 2025 ACOG Annual Clinical & Scientific Meeting reveals that a self-screening survey with educational videos enables most patients to determine medication abortion eligibility without an ultrasound.
Read More